This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Grassby, P. F Articles by Hutchings, L. Search for Related Content PubMed PubMed Citation Articles by Grassby, P. F Articles by Hutchings, L. Social Bookmarking                         What's this?

Drug combinations in syringe drivers: the compatibility and stability of diamorphine with cyclizine and haloperidol

St Mary's Pharmaceutical Unit, Llandough NHS Trust, Penarth, South Glamorgan

Lynne Hutchings

St Mary's Pharmaceutical Unit, Llandough NHS Trust, Penarth, South Glamorgan

The compatibility and stability of 28 combinations of diamorphine hydrochloride (5-100 mg/ml) with cyclizine lactate (5-50 mg/ml), eight combinations of diamorphine (10-100 mg/ml) with haloperidol (2-4 mg/ml) and eight combinations of all three drugs was assessed after storage in 1 ml polypropylene syringes. Samples were stored for periods up to seven days in the light and at room temperature (22°C).

Five combinations of diamorphine with cyclizine precipitated immediately upon preparation. After analysis and determination of t_90% values (the time taken for 10% degradation), 16 of the remaining 23 combinations were judged to be compatible (no signs of crystallization or precipitation) and stable (less than 10% loss of potency of either drug) after storage for 24 h. After seven days storage only four remained compatible and stable. The results indicate that ratios of diamorphine to cyclizine of 1:1 are stable at concentrations up to 20 mg/ml. An increase in diamorphine concentration necessitates a reduction in cyclizine to 10 mg/ml, and an increase in cyclizine concentration necessitates a reduction in concentration of diamorphine to 15 mg/ml to maintain stability over 24 h.

All the combinations of diamorphine with haloperidol remained compatible and stable for seven days. The addition of haloperidol (2 mg/ml) to the diamorphine and cyclizine combinations had no detrimental effect on their compatibility and stability.

A stability curve is included as an easy way for palliative care personnel to avoid potential problems with incompatibilities and reduced stability when using these combinations. Furthermore, to reduce the possibility of precipitation with mixtures containing cyclizine, the use of 0.9% sodium chloride should be avoided.

Key Words: cyclizine • diacetylmorphine • drug incompatibility • drug stability • haloperidol

Palliative Medicine, Vol. 11, No. 3, 217-224 (1997)
DOI: 10.1177/026921639701100306


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. Wilcock, J. K Jacob, S. Charlesworth, E. Harris, M. Gibbs, and H. Allsop Drugs given by a syringe driver: a prospective multicentre survey of palliative care services in the UK Palliative Medicine, October 1, 2006; 20(7): 661 - 664. [Abstract] [PDF]

				C A O'Doherty, E J Hall, L Schofield, and G Zeppetella Drugs and syringe drivers: A survey of adult specialist palliative care practice in the United Kingdom and Eire Palliative Medicine, March 1, 2001; 15(2): 149 - 154. [Abstract] [PDF]

				S. A. Bernard and E. Bruera Drug Interactions in Palliative Care J. Clin. Oncol., April 1, 2000; 18(8): 1780 - 1799. [Abstract] [Full Text] [PDF]